ViroLogic changes name to Monogram Biosciences

By Kimberly N. Alleyne

Stroudsburg, Pa., Sept. 6 - ViroLogic, Inc. announced Tuesday it is changing its name to Monogram Biosciences, Inc.

Effective Sept. 7, the company's common stock will trade under the ticker symbol "MGRM" instead of the current "VLGC." It will continue to be quoted on the Nasdaq National Market. The contingent value rights will trade under the symbol "MGRMR.OB."

"Our new name reflects our broader commitment to extend our pioneering efforts in individualized medicine beyond viral diseases and into oncology and other serious diseases," stated William D. Young, Monogram's chairman and chief executive officer, in a news release.

Monogram is headquartered in South San Francisco, Calif. The company develops and commercializes innovative products to help guide and improve the treatment of infectious diseases, cancer and other serious diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.